Mirae Asset Global ETFs Holdings
DMAC icon

Mirae Asset Global ETFs Holdings’s DiaMedica Therapeutics DMAC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
16,158
+374
+2% +$2.96K ﹤0.01% 2625
2025
Q4 		$126K Buy
15,784
+1,038
+7% +$7.76K ﹤0.01% 2567
2025
Q3 		$101K Buy
14,746
+321
+2% +$1.74K ﹤0.01% 2650
2025
Q2 		$56.3K Buy
+14,425
New +$56.3K ﹤0.01% 2855

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's DMAC Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its DiaMedica Therapeutics (DMAC) stake by 2.4% in Q1 2026, buying an estimated $2.96K and bringing the position to 16,158 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2625.

Mirae Asset Global ETFs Holdings first reported a position in DMAC in Q2 2025 and has held it in 4 quarters since. The position peaked at $126K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 16,158 shares of DiaMedica Therapeutics worth $109K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 374 DiaMedica Therapeutics shares in Q1 2026, an estimated $2.96K.
  • DiaMedica Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2625 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's DiaMedica Therapeutics position peaked at $126K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.